AYTU BIOPHARMA, INC Increase (Decrease) in Accounts Receivable
AYTU BIOPHARMA, INC (AYTU) reported Increase (Decrease) in Accounts Receivable of -$8.38 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-09-22
- AYTU BIOPHARMA, INC increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$1.71M.
- AYTU BIOPHARMA, INC increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$6.43M, a 161.25% decline year-over-year.
- AYTU BIOPHARMA, INC increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$2.30M, a 201.32% decline year-over-year.
- AYTU BIOPHARMA, INC increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $2.07M.
- AYTU BIOPHARMA, INC increase (decrease) in accounts receivable for fiscal 2026 was -$8.38M, a 209.79% decline from fiscal 2025.
- AYTU BIOPHARMA, INC increase (decrease) in accounts receivable for fiscal 2025 was $7.63M.
- AYTU BIOPHARMA, INC increase (decrease) in accounts receivable for fiscal 2024 was -$5.20M, a 172.71% decline from fiscal 2023.
- AYTU BIOPHARMA, INC increase (decrease) in accounts receivable for fiscal 2023 was $7.15M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | -$8.14M derived: sum of 2 quarters · filed 2026-09-22 | -$10.45M derived: sum of 3 quarters · filed 2026-09-22 | -$8.38M 10-K · filed 2026-09-22 | ||||
| 2026-03-31 | -$6.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$8.74M derived: sum of 2 quarters · filed 2026-05-13 | -$6.67M 10-Q · filed 2026-05-13 | -$11.34M derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2025-12-31 | -$2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | -$232.00K 10-Q · filed 2026-02-03 | -$4.90M derived: sum of 3 quarters · filed 2026-09-22 | $5.60M derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2025-09-30 | $2.07M 10-Q · filed 2025-11-13 | -$2.60M derived: sum of 2 quarters · filed 2026-09-22 | $7.91M derived: sum of 3 quarters · filed 2026-09-22 | $10.18M derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2025-06-30 | -$4.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | $5.83M derived: sum of 2 quarters · filed 2026-09-22 | $8.11M derived: sum of 3 quarters · filed 2026-09-22 | $7.63M 10-K · filed 2026-09-22 | ||||
| 2025-03-31 | $10.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $12.78M derived: sum of 2 quarters · filed 2026-05-13 | $12.30M 10-Q · filed 2026-05-13 | $6.57M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $1.79M 10-Q · filed 2026-02-03 | -$3.94M derived: sum of 3 quarters · filed 2026-02-03 | -$4.97M derived: sum of 4 quarters · filed 2026-02-03 | ||||
| 2024-09-30 | -$478.00K 10-Q · filed 2025-11-13 | -$6.21M derived: sum of 2 quarters · filed 2025-11-13 | -$478.00K 10-Q · filed 2024-11-13 | -$6.62M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$5.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | -$6.77M derived: sum of 2 quarters · filed 2025-09-23 | -$6.15M derived: sum of 3 quarters · filed 2025-09-23 | -$5.20M 10-K · filed 2025-09-23 | -$5.32M 10-K · filed 2024-09-26 | |||
| 2024-03-31 | -$1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | -$414.00K derived: sum of 2 quarters · filed 2025-05-14 | $531.00K 10-Q · filed 2025-05-14 | $988.00K 10-Q · filed 2024-05-15 | -$4.65M derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $621.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-12 | $1.57M 10-Q · filed 2025-02-12 | $466.00K 10-Q · filed 2024-02-14 | -$3.62M derived: sum of 3 quarters · filed 2025-02-12 | $4.88M derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2023-09-30 | $945.00K 10-Q · filed 2023-11-14 | -$4.24M derived: sum of 2 quarters · filed 2024-09-26 | $1.68M 10-Q · filed 2024-11-13 | $1.89M derived: sum of 4 quarters · filed 2024-09-26 | ||||
| 2023-06-30 | -$5.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-26 | $3.32M derived: sum of 2 quarters · filed 2024-09-26 | $941.00K derived: sum of 3 quarters · filed 2024-09-26 | $7.15M 10-K · filed 2024-09-26 | ||||
| 2023-03-31 | $8.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | $6.12M derived: sum of 2 quarters · filed 2024-05-15 | $12.34M 10-Q · filed 2024-05-15 | $6.45M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | $3.83M 10-Q · filed 2024-02-14 | -$2.05M derived: sum of 3 quarters · filed 2024-02-14 | $2.49M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-09-30 | $6.21M 10-Q · filed 2023-11-14 | $326.00K derived: sum of 2 quarters · filed 2023-11-14 | $4.87M derived: sum of 3 quarters · filed 2023-11-14 | $6.20M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$5.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-12 | -$1.35M derived: sum of 2 quarters · filed 2023-10-12 | -$8.00K derived: sum of 3 quarters · filed 2023-10-12 | -$6.53M 10-K · filed 2023-10-12 | ||||
| 2022-03-31 | $4.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | $5.88M derived: sum of 2 quarters · filed 2023-05-11 | -$647.00K 10-Q · filed 2023-05-11 | -$427.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $1.34M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-02-21 | -$5.19M 10-Q · filed 2023-02-21 | -$4.97M derived: sum of 3 quarters · filed 2023-02-21 | -$8.70M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-09-30 | -$6.53M 10-Q/A · filed 2023-02-21 | -$6.30M derived: sum of 2 quarters · filed 2023-02-21 | -$10.04M derived: sum of 3 quarters · filed 2023-02-21 | -$9.01M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-30 | $220.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | -$3.52M derived: sum of 2 quarters · filed 2022-09-27 | -$2.48M derived: sum of 3 quarters · filed 2022-09-27 | -$1.54M 10-K · filed 2022-09-27 | ||||
| 2021-03-31 | -$3.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | -$2.70M derived: sum of 2 quarters · filed 2022-05-16 | -$1.76M 10-Q · filed 2022-05-16 | -$1.77M 10-Q · filed 2021-05-17 | -$6.39M derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $1.97M 10-Q · filed 2022-02-14 | $1.97M 10-Q · filed 2021-02-11 | -$2.65M derived: sum of 3 quarters · filed 2022-02-14 | $2.08M derived: sum of 4 quarters · filed 2022-02-14 | |||
| 2020-09-30 | $937.00K 10-Q · filed 2021-11-15 | $928.89K 10-Q · filed 2020-11-12 | -$3.69M derived: sum of 2 quarters · filed 2021-11-15 | $1.04M derived: sum of 3 quarters · filed 2021-11-15 | $4.53M derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | -$4.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $104.64K derived: sum of 2 quarters · filed 2021-09-28 | $3.60M derived: sum of 3 quarters · filed 2021-09-28 | $3.56M 10-K · filed 2021-09-28 | $3.56M 10-K · filed 2020-10-06 | |||
| 2020-03-31 | $4.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-17 | $8.22M derived: sum of 2 quarters · filed 2021-05-17 | $8.18M 10-Q · filed 2021-05-17 | $8.55M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $3.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-11 | $3.46M 10-Q · filed 2021-02-11 | $3.82M derived: sum of 3 quarters · filed 2021-02-11 | $3.71M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-09-30 | -$35.36K 10-Q · filed 2020-11-12 | $329.07K derived: sum of 2 quarters · filed 2020-11-12 | $222.94K derived: sum of 3 quarters · filed 2020-11-12 | $945.37K derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $364.43K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06 | $258.30K derived: sum of 2 quarters · filed 2020-10-06 | $980.73K derived: sum of 3 quarters · filed 2020-10-06 | $1.16M 10-K · filed 2020-10-06 | ||||
| 2019-03-31 | -$106.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | $616.30K derived: sum of 2 quarters · filed 2020-05-15 | $797.58K 10-Q · filed 2020-05-15 | $643.88K derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | $722.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | $903.71K 10-Q · filed 2020-02-14 | $750.01K derived: sum of 3 quarters · filed 2020-02-14 | $105.05K derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-09-30 | $181.27K 10-Q · filed 2019-11-14 | $27.58K derived: sum of 2 quarters · filed 2019-11-14 | -$617.38K derived: sum of 3 quarters · filed 2019-11-14 | -$451.79K derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | -$153.69K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | -$798.65K derived: sum of 2 quarters · filed 2019-09-26 | -$633.06K derived: sum of 3 quarters · filed 2019-09-26 | $50.74K 10-K · filed 2019-09-26 | ||||
| 2018-03-31 | -$644.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-14 | -$479.37K derived: sum of 2 quarters · filed 2019-05-14 | $204.44K 10-Q · filed 2019-05-14 | $379.36K derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $165.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-14 | $849.40K 10-Q · filed 2019-05-14 | $1.02M derived: sum of 3 quarters · filed 2019-05-14 | $784.46K derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-09-30 | $683.81K 10-Q · filed 2018-11-07 | $858.73K derived: sum of 2 quarters · filed 2018-11-07 | $618.87K derived: sum of 3 quarters · filed 2018-11-07 | $691.82K derived: sum of 4 quarters · filed 2018-11-07 | ||||
| 2017-06-30 | $174.92K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-06 | -$64.94K derived: sum of 2 quarters · filed 2018-09-06 | $8.02K derived: sum of 3 quarters · filed 2018-09-06 | $355.03K 10-K · filed 2018-09-06 | ||||
| 2017-03-31 | -$239.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | -$166.90K derived: sum of 2 quarters · filed 2018-05-14 | $180.11K 10-Q · filed 2018-05-14 | $258.26K derived: sum of 4 quarters · filed 2018-05-14 | ||||
| 2016-12-31 | $72.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | $419.97K 10-Q · filed 2018-02-08 | $498.12K derived: sum of 3 quarters · filed 2018-02-08 | $293.93K derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-09-30 | $347.01K 10-Q · filed 2017-11-09 | $425.17K derived: sum of 2 quarters · filed 2017-11-09 | $220.97K derived: sum of 3 quarters · filed 2017-11-09 | $341.51K derived: sum of 4 quarters · filed 2017-11-09 | ||||
| 2016-06-30 | $78.15K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | -$126.04K derived: sum of 2 quarters · filed 2017-08-31 | -$5.50K derived: sum of 3 quarters · filed 2017-08-31 | $5.37K 10-K · filed 2017-08-31 | ||||
| 2016-03-31 | -$204.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | -$83.66K derived: sum of 2 quarters · filed 2017-05-11 | -$72.78K 10-Q · filed 2017-05-11 | $83.24K derived: sum of 4 quarters · filed 2017-05-11 | ||||
| 2015-12-31 | $120.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | $131.41K 10-Q · filed 2017-02-09 | $287.43K derived: sum of 3 quarters · filed 2017-02-09 | $281.56K derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2015-09-30 | $10.87K 10-Q · filed 2016-11-07 | $166.89K derived: sum of 2 quarters · filed 2016-11-07 | $161.02K derived: sum of 3 quarters · filed 2016-11-07 | |||||
| 2015-06-30 | $156.02K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-01 | $150.15K derived: sum of 2 quarters · filed 2016-09-01 | $157.06K 10-K · filed 2016-09-01 | |||||
| 2015-03-31 | -$5.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-11 | $1.04K 10-Q · filed 2016-05-11 | ||||||
| 2014-12-31 | $6.91K 10-Q · filed 2016-02-11 | |||||||
| 2014-03-31 | -$24.00K 10-Q · filed 2015-05-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |